U-IMLFF

Q:IMLFF - INMED PHARMACEUTICALS INC - http://www.inmedpharma.com

12:28:55 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
IMLFF - Q	not subscribed					3.5953	+0.0353	1.0	3.8	14	33	3.505 3.66208 3.505	10.626 3.40	12:12:08	Sep 24	15 min RT 2¢

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
OTC Markets Indicators -- Primary Market: OTC Markets -- Tier: OTCQX International -- Status: Active

Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · 1yr Bulletins · Historical · Portfolio

Recent Trades - Last 10 of 33

Time ET	Ex	Price	Change	Volume
12:12:08	Q	3.55	-0.01	47
12:09:23	Q	3.55	-0.01	30
11:42:08	Q	3.55	-0.01	33
11:39:45	Q	3.60	0.04	25
11:39:00	Q	3.5953	0.0353	100
11:21:07	Q	3.55	-0.01	6
11:16:41	Q	3.58	0.02	100
11:16:41	Q	3.58	0.02	100
11:16:41	Q	3.58	0.02	100
11:16:41	Q	3.58	0.02	75

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Date ET	Symbol	Type	Headline
2020-09-24 07:30	U:IMLFF	News Release200	InMed Announces Completion of Subject Treatments in Second Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects
2020-09-22 07:30	U:IMLFF	News Release200	InMed Pharmaceuticals Announces Additional IntegraSyn™ Patent Filing
2020-09-08 07:30	U:IMLFF	News Release200	InMed Pharmaceuticals Reports Full Year Fiscal 2020 Financial Results and Provides Business Update
2020-09-02 07:30	U:IMLFF	News Release200	InMed Pharmaceuticals to Report Full Year Fiscal 2020 Financial Results and Business Update on September 8, 2020

Date ET

Symbol

Type

Headline

2020-09-24 07:30

U:IMLFF

News Release

InMed Announces Completion of Subject Treatments in Second Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects

2020-09-22 07:30

U:IMLFF

News Release

InMed Pharmaceuticals Announces Additional IntegraSyn™ Patent Filing